:
Zylopen 500/125 mg is a combination antibiotic medication manufactured by Radiant Pharmaceuticals Ltd. It contains two active ingredients: Amoxicillin 500 mg and Clavulanic Acid 125 mg. Amoxicillin is a broad-spectrum penicillin-type antibiotic that inhibits bacterial cell wall synthesis, leading to the destruction of bacteria. Clavulanic Acid is a beta-lactamase inhibitor that protects Amoxicillin from degradation by beta-lactamase enzymes produced by certain bacteria, thereby enhancing its effectiveness against resistant strains. This combination is used to treat a variety of bacterial infections, including upper and lower respiratory tract infections, urinary tract infections, skin and soft tissue infections, bone and joint infections, and intra-abdominal infections. Zylopen 500/125 mg is available in tablet form and is typically taken at the start of a meal to improve absorption and reduce gastrointestinal side effects. It is important to use this medication under the guidance of a healthcare provider to ensure its appropriateness and to minimize the risk of antibiotic resistance.ARTO: Bangladesh Patient Supoort Network+6